BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 20544796)

  • 1. NMR studies of the C-terminus of alpha4 reveal possible mechanism of its interaction with MID1 and protein phosphatase 2A.
    Du H; Massiah MA
    PLoS One; 2011; 6(12):e28877. PubMed ID: 22194938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three Type 2A protein phosphatases, PP2Ac, PP4c and PP6c, are differentially regulated by Alpha4.
    LeNoue-Newton ML; Wadzinski BE; Spiller BW
    Biochem Biophys Res Commun; 2016 Jun; 475(1):64-9. PubMed ID: 27169767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MID1 gene product in physiology and disease.
    Baldini R; Mascaro M; Meroni G
    Gene; 2020 Jul; 747():144655. PubMed ID: 32283114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
    Shearer RF; Iconomou M; Watts CK; Saunders DN
    Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes.
    Gudjonsson T; Altmeyer M; Savic V; Toledo L; Dinant C; Grøfte M; Bartkova J; Poulsen M; Oka Y; Bekker-Jensen S; Mailand N; Neumann B; Heriche JK; Shearer R; Saunders D; Bartek J; Lukas J; Lukas C
    Cell; 2012 Aug; 150(4):697-709. PubMed ID: 22884692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.
    LeNoue-Newton M; Watkins GR; Zou P; Germane KL; McCorvey LR; Wadzinski BE; Spiller BW
    J Biol Chem; 2011 May; 286(20):17665-71. PubMed ID: 21454489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TT Genotype of the
    Szudy-Szczyrek A; Mlak R; Mazurek M; Krajka T; Chocholska S; Bitkowska P; Jutrzenka M; Szczyrek M; Homa-Mlak I; Krajka A; Małecka-Massalska T; Hus M
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBR5 oncogene as an indicator of poor prognosis in gastric cancer.
    Ding F; Zhu X; Song X; Yuan P; Ren L; Chai C; Zhou W; Li X
    Exp Ther Med; 2020 Nov; 20(5):7. PubMed ID: 32934672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
    Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
    BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin and androgen R1881 induce pro-survival carboxypeptidase-D and EDD E3 ligase in triple-negative and HER2+ breast cancer.
    MacDonald TM; Thomas LN; Gupta A; Barnes PJ; Too CK
    Am J Cancer Res; 2020; 10(5):1321-1343. PubMed ID: 32509382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.
    MacDonald TM; Thomas LN; Daze E; Marignani P; Barnes PJ; Too CK
    Am J Cancer Res; 2019; 9(7):1484-1503. PubMed ID: 31392083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine-threonine protein phosphatases: Lost in translation.
    Kolupaeva V
    Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):83-89. PubMed ID: 30401537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic β-cells.
    Zhang X; Damacharla D; Ma D; Qi Y; Tagett R; Draghici S; Kowluru A; Yi Z
    Mol Cell Endocrinol; 2016 Mar; 424():1-11. PubMed ID: 26780722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of an alternatively spliced isoform of the human protein phosphatase 2Aα catalytic subunit.
    Migueleti DL; Smetana JH; Nunes HF; Kobarg J; Zanchin NI
    J Biol Chem; 2012 Feb; 287(7):4853-62. PubMed ID: 22167190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).
    Aranda-Orgillés B; Rutschow D; Zeller R; Karagiannidis AI; Köhler A; Chen C; Wilson T; Krause S; Roepcke S; Lilley D; Schneider R; Schweiger S
    J Biol Chem; 2011 Nov; 286(46):39945-57. PubMed ID: 21930711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative RNA helicase HELZ promotes cell proliferation, translation initiation and ribosomal protein S6 phosphorylation.
    Hasgall PA; Hoogewijs D; Faza MB; Panse VG; Wenger RH; Camenisch G
    PLoS One; 2011; 6(7):e22107. PubMed ID: 21765940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EDD inhibits ATM-mediated phosphorylation of p53.
    Ling S; Lin WC
    J Biol Chem; 2011 Apr; 286(17):14972-82. PubMed ID: 21383020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha4 phosphoprotein interacts with EDD E3 ubiquitin ligase and poly(A)-binding protein.
    McDonald WJ; Sangster SM; Moffat LD; Henderson MJ; Too CK
    J Cell Biochem; 2010 Aug; 110(5):1123-9. PubMed ID: 20544796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin-inducible EDD E3 ubiquitin ligase binds to α4 phosphoprotein to regulate ubiquitination and degradation of protein phosphatase PP2Ac.
    McDonald WJ; Thomas LN; Koirala S; Too CKL
    Mol Cell Endocrinol; 2014 Jan; 382(1):254-261. PubMed ID: 24145130
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.